Brought to you by www.DealSearchOnline.com
August 6, 2012 Issue:
Recent Health Care M&A Deals
Spotlight on: Pharmaceuticals
Spotlight on: Venture Capital
Conference Calendar
Recent Health Care M&A Deals
BIOTECHNOLOGY
Acquirer
Target
Price
Metabolon
Lipomics Technologies
N/A
Stemgent
Asterand’s Human Tissue Business
$9.0 million
E-HEALTH
Acquirer
Target
Price
Accenture
Octagon Research Solutions
N/A
Roper Industries, Inc.
Sunquest Information Systems, Inc.
$1.42 billion
MEDICAL DEVICES
Acquirer
Target
Price
Haemonetics Corporation
Pall Corporation’s Transfusion Medicine Business
$550.0 million
Is Your Company a Power User of Merger and Acquisition Data?
Drive the price of data down to less than 3 cents per item. Call 1-800-248-1668 to learn about our frequency discounts. Go to http://www.dealsearchonline.com, an easy-to-use, award-winning database. This specialized database is an essential 24/7 source for details on health care mergers and acquisitions covering 13 sectors. With approximately 20,000 records of investments and contact names (including e-mail addresses), you’ll get the information you need to make an informed decision any time of the day or night. Call 1-800-248-1668 to learn about our frequency discounts.
Spotlight on: Pharmaceuticals
This past month produced several acquisitions in the pharmaceutical industry. Our transaction table includes a brief summary of each deal and purchase details…..Read more
How can we serve you better? Complete our brief survey for a chance to win $250 from AMEX!
What is most important to your business? Is there something you would like to see in one of our publications? We are dedicated to being an integral part of keeping your business ahead of the competition. We would love to hear from you. Fill out our brief publications survey and you will be entered for a chance to win one of two $250 American Express gift cards! http://www.levinassociates.com/pubsurvey
Spotlight on: Venture Capital
In the venture capital arena, Third Rock Ventures launched Global Blood Therapeutics with a $40.7 million Series A financing. Its lead program focuses on Sickle Cell Disease SCD), one of the earliest rare genetic diseases defined on a molecular basis……..Read more
Conference Calendar…Click here to see more
